RBC Capital Reiterates Outperform on HealthEquity, Maintains $92 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Sean Dodge has reiterated an Outperform rating on HealthEquity (NASDAQ:HQY) and maintained a price target of $92.
June 04, 2024 | 2:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has reiterated an Outperform rating on HealthEquity (NASDAQ:HQY) and maintained a price target of $92, indicating continued confidence in the company's performance.
The reiteration of an Outperform rating and the maintenance of a $92 price target by RBC Capital suggests strong confidence in HealthEquity's future performance. This positive analyst rating is likely to boost investor sentiment and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100